|
Leader
|
|
|
00000nz a2200037n 45 0 |
|
001
|
|
|
WKP|Q85072044
(VIAF cluster)
(Authority/Source Record)
|
|
003
|
|
|
WKP |
|
005
|
|
|
20241121000229.0 |
|
008
|
|
|
241121nneanz||abbn n and d |
|
035
|
|
|
‡a
(WKP)Q85072044
|
|
024
|
|
|
‡a
0000-0002-3333-2621
‡2
orcid
|
|
024
|
|
|
‡a
16317021500
‡2
scopus
|
|
035
|
|
|
‡a
(OCoLC)Q85072044
|
|
100
|
0 |
|
‡a
Cláudia Marques
‡c
researcher (ORCID 0000-0002-3333-2621)
‡9
en
|
|
400
|
0 |
|
‡a
Cláudia Marques
‡c
onderzoeker
‡9
nl
|
|
670
|
|
|
‡a
Author's COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
|
|
670
|
|
|
‡a
Author's [Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort]
|
|
670
|
|
|
‡a
Author's IMPACT OF CHRONIC USE OF ANTIMALARIALS ON SARS-CoV-2 INFECTION IN PATIENTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES: PROTOCOL DESIGN FOR A MULTICENTRIC OBSERVATIONAL COHORT IN BRAZIL
|
|
670
|
|
|
‡a
Author's Investigation of latent tuberculosis infection in patients with psoriasis who are candidate for receiving immunobiological drugs.
|
|
670
|
|
|
‡a
Author's Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis
|
|
670
|
|
|
‡a
Author's Pilates method in the treatment of patients with Chikungunya fever: a randomized controlled trial
|
|
670
|
|
|
‡a
Author's The Role of PPAR Gamma in Systemic Sclerosis
|
|
909
|
|
|
‡a
(orcid) 0000000233332621
‡9
1
|
|
909
|
|
|
‡a
(scopus) 16317021500
‡9
1
|
|
919
|
|
|
‡a
peroxisomeproliferatoractivatedreceptoragonistspparsapromisingprospectinthetreatmentofpsoriasisandpsoriaticarthritis
‡A
Peroxisome proliferator-activated receptor agonists (PPARs): a promising prospect in the treatment of psoriasis and psoriatic arthritis
‡9
1
|
|
919
|
|
|
‡a
roleofppargammainsystemicsclerosis
‡A
The Role of PPAR Gamma in Systemic Sclerosis
‡9
1
|
|
919
|
|
|
‡a
pilatesmethodinthetreatmentofpatientswithchikungunyafeverarandomizedcontrolledtrial
‡A
Pilates method in the treatment of patients with Chikungunya fever: a randomized controlled trial
‡9
1
|
|
919
|
|
|
‡a
covid19inpatientswithrheumaticdiseaseswhatistherealmortalityrisk
‡A
COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
‡9
1
|
|
919
|
|
|
‡a
epidemiologicprofileofjuvenileonsetcomparedtoadultonsetspondyloarthritisinalargebraziliancohort
‡A
[Epidemiologic profile of juvenile-onset compared to adult-onset spondyloarthritis in a large Brazilian cohort]
‡9
1
|
|
919
|
|
|
‡a
impactofchronicuseofantimalarialsonsarscov2infectioninpatientswithimmunemediatedrheumaticdiseasesprotocoldesignforamulticentricobservationalcohortinbrazil
‡A
IMPACT OF CHRONIC USE OF ANTIMALARIALS ON SARS-CoV-2 INFECTION IN PATIENTS WITH IMMUNE-MEDIATED RHEUMATIC DISEASES: PROTOCOL DESIGN FOR A MULTICENTRIC OBSERVATIONAL COHORT IN BRAZIL
‡9
1
|
|
919
|
|
|
‡a
investigationoflatenttuberculosisinfectioninpatientswithpsoriasiswhoarecandidateforreceivingimmunobiologicaldrugs
‡A
Investigation of latent tuberculosis infection in patients with psoriasis who are candidate for receiving immunobiological drugs.
‡9
1
|
|
996
|
|
|
‡2
PTBNP|1763968
|
|
996
|
|
|
‡2
SUDOC|124686524
|
|
996
|
|
|
‡2
SZ|1029513058
|
|
996
|
|
|
‡2
PTBNP|1639738
|
|
996
|
|
|
‡2
LC|no2007090970
|
|
996
|
|
|
‡2
BLBNB|000254168
|
|
996
|
|
|
‡2
BLBNB|000431764
|
|
996
|
|
|
‡2
PLWABN|9810657401005606
|
|
996
|
|
|
‡2
PTBNP|1613987
|
|
996
|
|
|
‡2
DNB|133980006
|
|
996
|
|
|
‡2
PTBNP|1419100
|
|
996
|
|
|
‡2
ISNI|0000000086986018
|
|
996
|
|
|
‡2
PTBNP|1932453
|
|
996
|
|
|
‡2
CAOONL|ncf11699462
|
|
996
|
|
|
‡2
NTA|436965577
|
|
996
|
|
|
‡2
BIBSYS|11040805
|
|
996
|
|
|
‡2
DNB|1029513058
|
|
996
|
|
|
‡2
PTBNP|1928987
|
|
996
|
|
|
‡2
SUDOC|273509993
|
|
996
|
|
|
‡2
RERO|A000105494
|
|
996
|
|
|
‡2
PTBNP|1171887
|
|
996
|
|
|
‡2
PTBNP|1857573
|
|
996
|
|
|
‡2
LC|n 86853770
|
|
996
|
|
|
‡2
ISNI|0000000061601257
|
|
996
|
|
|
‡2
ISNI|0000000068177911
|
|
996
|
|
|
‡2
PTBNP|1548765
|
|
996
|
|
|
‡2
NTA|297542818
|
|
996
|
|
|
‡2
RERO|A018711268
|
|
996
|
|
|
‡2
BLBNB|000596583
|
|
996
|
|
|
‡2
LC|n 93042154
|
|
996
|
|
|
‡2
NUKAT|n 2021084051
|
|
996
|
|
|
‡2
BLBNB|001116599
|
|
996
|
|
|
‡2
ISNI|0000000079868590
|
|
996
|
|
|
‡2
PTBNP|1839182
|
|
997
|
|
|
‡a
0 0 lived 0 0
‡9
1
|
